Two Janssen Drugs – Sylvant and Olysio – Get CHMP Backing
This article was originally published in The Pink Sheet Daily
Executive Summary
By backing Janssen’s Sylvant, the CHMP has effectively cleared for approval Europe’s first medicine for Castleman's disease. J&J’s unit also received a positive opinion from the CHMP for its new hepatitis C pill Olysio.